2023-03-012024-02-292024-02-29false13230371BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED2024-08-0185600iso4217:GBPxbrli:pure132303712023-03-01132303712024-02-29132303712023-03-012024-02-29132303712022-03-01132303712023-02-28132303712022-03-012023-02-2813230371bus:SmallEntities2023-03-012024-02-2913230371bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2913230371bus:FullAccounts2023-03-012024-02-2913230371bus:PrivateLimitedCompanyLtd2023-03-012024-02-2913230371core:WithinOneYear2024-02-2913230371core:AfterOneYear2024-02-2913230371core:WithinOneYear2023-02-2813230371core:AfterOneYear2023-02-2813230371core:ShareCapital2024-02-2913230371core:SharePremium2024-02-2913230371core:RevaluationReserve2024-02-2913230371core:OtherReservesSubtotal2024-02-2913230371core:RetainedEarningsAccumulatedLosses2024-02-2913230371core:ShareCapital2023-02-2813230371core:SharePremium2023-02-2813230371core:RevaluationReserve2023-02-2813230371core:OtherReservesSubtotal2023-02-2813230371core:RetainedEarningsAccumulatedLosses2023-02-2813230371core:LandBuildings2024-02-2913230371core:PlantMachinery2024-02-2913230371core:Vehicles2024-02-2913230371core:FurnitureFittings2024-02-2913230371core:OfficeEquipment2024-02-2913230371core:NetGoodwill2024-02-2913230371core:IntangibleAssetsOtherThanGoodwill2024-02-2913230371core:ListedExchangeTraded2024-02-2913230371core:UnlistedNon-exchangeTraded2024-02-2913230371core:LandBuildings2023-02-2813230371core:PlantMachinery2023-02-2813230371core:Vehicles2023-02-2813230371core:FurnitureFittings2023-02-2813230371core:OfficeEquipment2023-02-2813230371core:NetGoodwill2023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2023-02-2813230371core:ListedExchangeTraded2023-02-2813230371core:UnlistedNon-exchangeTraded2023-02-2813230371core:LandBuildings2023-03-012024-02-2913230371core:PlantMachinery2023-03-012024-02-2913230371core:Vehicles2023-03-012024-02-2913230371core:FurnitureFittings2023-03-012024-02-2913230371core:OfficeEquipment2023-03-012024-02-2913230371core:NetGoodwill2023-03-012024-02-2913230371core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2913230371core:ListedExchangeTraded2023-03-012024-02-2913230371core:UnlistedNon-exchangeTraded2023-03-012024-02-2913230371core:MoreThanFiveYears2023-03-012024-02-2913230371core:Non-currentFinancialInstruments2024-02-2913230371core:Non-currentFinancialInstruments2023-02-2813230371dpl:CostSales2023-03-012024-02-2913230371dpl:DistributionCosts2023-03-012024-02-2913230371core:LandBuildings2023-03-012024-02-2913230371core:PlantMachinery2023-03-012024-02-2913230371core:Vehicles2023-03-012024-02-2913230371core:FurnitureFittings2023-03-012024-02-2913230371core:OfficeEquipment2023-03-012024-02-2913230371dpl:AdministrativeExpenses2023-03-012024-02-2913230371core:NetGoodwill2023-03-012024-02-2913230371core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2913230371dpl:GroupUndertakings2023-03-012024-02-2913230371dpl:ParticipatingInterests2023-03-012024-02-2913230371dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2913230371core:ListedExchangeTraded2023-03-012024-02-2913230371dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2913230371core:UnlistedNon-exchangeTraded2023-03-012024-02-2913230371dpl:CostSales2022-03-012023-02-2813230371dpl:DistributionCosts2022-03-012023-02-2813230371core:LandBuildings2022-03-012023-02-2813230371core:PlantMachinery2022-03-012023-02-2813230371core:Vehicles2022-03-012023-02-2813230371core:FurnitureFittings2022-03-012023-02-2813230371core:OfficeEquipment2022-03-012023-02-2813230371dpl:AdministrativeExpenses2022-03-012023-02-2813230371core:NetGoodwill2022-03-012023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2813230371dpl:GroupUndertakings2022-03-012023-02-2813230371dpl:ParticipatingInterests2022-03-012023-02-2813230371dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2813230371core:ListedExchangeTraded2022-03-012023-02-2813230371dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2813230371core:UnlistedNon-exchangeTraded2022-03-012023-02-2813230371core:NetGoodwill2024-02-2913230371core:IntangibleAssetsOtherThanGoodwill2024-02-2913230371core:LandBuildings2024-02-2913230371core:PlantMachinery2024-02-2913230371core:Vehicles2024-02-2913230371core:FurnitureFittings2024-02-2913230371core:OfficeEquipment2024-02-2913230371core:AfterOneYear2024-02-2913230371core:WithinOneYear2024-02-2913230371core:ListedExchangeTraded2024-02-2913230371core:UnlistedNon-exchangeTraded2024-02-2913230371core:ShareCapital2024-02-2913230371core:SharePremium2024-02-2913230371core:RevaluationReserve2024-02-2913230371core:OtherReservesSubtotal2024-02-2913230371core:RetainedEarningsAccumulatedLosses2024-02-2913230371core:NetGoodwill2023-02-2813230371core:IntangibleAssetsOtherThanGoodwill2023-02-2813230371core:LandBuildings2023-02-2813230371core:PlantMachinery2023-02-2813230371core:Vehicles2023-02-2813230371core:FurnitureFittings2023-02-2813230371core:OfficeEquipment2023-02-2813230371core:AfterOneYear2023-02-2813230371core:WithinOneYear2023-02-2813230371core:ListedExchangeTraded2023-02-2813230371core:UnlistedNon-exchangeTraded2023-02-2813230371core:ShareCapital2023-02-2813230371core:SharePremium2023-02-2813230371core:RevaluationReserve2023-02-2813230371core:OtherReservesSubtotal2023-02-2813230371core:RetainedEarningsAccumulatedLosses2023-02-2813230371core:NetGoodwill2022-03-0113230371core:IntangibleAssetsOtherThanGoodwill2022-03-0113230371core:LandBuildings2022-03-0113230371core:PlantMachinery2022-03-0113230371core:Vehicles2022-03-0113230371core:FurnitureFittings2022-03-0113230371core:OfficeEquipment2022-03-0113230371core:AfterOneYear2022-03-0113230371core:WithinOneYear2022-03-0113230371core:ListedExchangeTraded2022-03-0113230371core:UnlistedNon-exchangeTraded2022-03-0113230371core:ShareCapital2022-03-0113230371core:SharePremium2022-03-0113230371core:RevaluationReserve2022-03-0113230371core:OtherReservesSubtotal2022-03-0113230371core:RetainedEarningsAccumulatedLosses2022-03-0113230371core:AfterOneYear2023-03-012024-02-2913230371core:WithinOneYear2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913230371core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2913230371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2913230371core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813230371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813230371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813230371bus:Director12023-03-012024-02-29

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED

Registered Number
13230371
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Company Information
for the year from 1 March 2023 to 29 February 2024

Director

G Forrester

Registered Address

179 Park Lane
Poynton
SK12 1RH

Registered Number

13230371 (England and Wales)
BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,590810
1,590810
Current assets
Debtors42-
Cash at bank and on hand8,88817,944
8,89017,944
Creditors amounts falling due within one year5(11,997)(13,221)
Net current assets (liabilities)(3,107)4,723
Total assets less current liabilities(1,517)5,533
Net assets(1,517)5,533
Capital and reserves
Called up share capital100100
Profit and loss account(1,617)5,433
Shareholders' funds(1,517)5,533
The financial statements were approved and authorised for issue by the Director on 1 August 2024, and are signed on its behalf by:
G Forrester
Director
Registered Company No. 13230371
BRIDGING THE GAP FOR HEALTH PRACTITIONERS LIMITED
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment20
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 March 23900900
Additions1,0661,066
At 29 February 241,9661,966
Depreciation and impairment
At 01 March 239090
Charge for year286286
At 29 February 24376376
Net book value
At 29 February 241,5901,590
At 28 February 23810810
4.Debtors: amounts due within one year

2024

2023

££
Other debtors2-
Total2-
Short term trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security5,2005,009
Other creditors6,7978,212
Total11,99713,221
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.